Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma

References

• Egan K. M., Seddon J. M., Glynn R. J., Gragoudas E. S., Albert D. Epidemiologic aspects of uveal melanoma. Surv. Ophthalmol. 1988; 32: 239–251
   PubMed Web of Science ®Google Scholar
• Jensen O. A. Malignant melanomas of the human uvea. Acta Ophthalmol. 1988; 60: 161–182
   Google Scholar
• Nicolson G. L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Met. Rev. 1988; 7: 143–188
   PubMed Web of Science ®Google Scholar
• Pauli B. U., Augustin‐Voss H. G., El‐Sabban M., Johnson R. C., Hammer D. A. Organ‐preference of metastasis. Cancer Met. Rev. 1990; 9: 175–189
   PubMed Web of Science ®Google Scholar
• Eihorn L. H., Burgee M. A., Vallejos C., Bodey G. P., Gutterman J., Mavligit G., Hers E. M., Luce J. K., Frei E., Freireich E. J., Gottlieb J. A. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res. 1974; 34: 1995–2005
   PubMed Web of Science ®Google Scholar
• Stehlin J. S., Hills W. J., Rufino C. Disseminated melanoma: biologic behavior and treatment. Arch. Surg. 1967; 94: 495–501
   PubMedGoogle Scholar
• Rajpal S., Moore R., Karakousis C. P. Survival in metastatic ocular melanoma. Cancer 1983; 5: 334–340
   Google Scholar
• Einhorn L. H., Burgess M. A., Gottlieb J. A. Metastatic patterns of choroidal melanoma. Cancer 1974; 34: 1001–1004
   PubMed Web of Science ®Google Scholar
• Char D. Metastatic choroidal melanoma. Am. J. Ophthalmol. 1978; 86: 76–80
   PubMed Web of Science ®Google Scholar
• Donoso L. A., Berd D., Augsburger J. J., Mastrongelo M. J., Shields J. A. Metastatic uveal melanoma: pretherapy serum liver enzyme and liver scan abnormalities. Arch. Ophthalmmol. 1985; 103: 796–798
   PubMedGoogle Scholar
• Iwamoto Y., Robey F. A., Graf J., Sasaki M., Kleinman H. K., Yamada Y., Martin G. R. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238: 1132–1134
   PubMed Web of Science ®Google Scholar
• Humphries M. J., Olden K., Yamada K. M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467–470
   PubMed Web of Science ®Google Scholar
• Albini A., Iwamoto Y., Kleinman H. K., Martin G. R., Aaronson S. A., Kozlowski J. M., McEwan R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987; 47: 3239–3245
   PubMed Web of Science ®Google Scholar
• Humphries M. J., Matsumoto K., White S. L., Olden K. Investigation of the antimetastatic effects of agents that inhibit cell adhesion or protein glycosylation. J. Nat. Med. Assoc. 1987; 79: 411–419
   PubMed Web of Science ®Google Scholar
• Cheresh D. A., Pytela R., Pierschbacher M. D., Klier F. G., Ruoslahti E., Reisfeld R. A. An arg‐gly‐asp directed receptor on the surface of human melanoma cells exists in a divalent cation‐dependent functional complex with the disialoganglioside GD2. J. Cell Biol. 1987; 105: 1163–1173
   PubMed Web of Science ®Google Scholar
• Iliopoulos D., Ernst C., Steplewski Z., Jambrosic J. A., Rodeck U., Herlyn M., Clark W. H., Jr, Koprowski H., Herlyn D. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J. Natl. Cancer Inst. 1989; 81: 440–444
   PubMedGoogle Scholar
• Kan‐Mitchell J., Mitchell M. S., Rao N., Liggett P. E. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest. Ophthalmol. Vis. Sci. 1989; 30: 829–834
   PubMed Web of Science ®Google Scholar
• Ksander B. R., Rubsamen P. E., Olsen K. R., Cousins S. W., Streilein J. W. Studies of tumor‐infiltrating‐lymphocytes from a human choroidal melanoma. Invest. Ophthalmol. Vis. Sci. 1991; 32: 3198–3208
   PubMed Web of Science ®Google Scholar
• Sanborn G., Niederkorn J., Kan‐Mitchell J., Albert D. Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylornithine. Graefe's Arch. Ophthalmol. 1992; 230: 72–77
   Google Scholar
• Mujoo K., Kipps J. T., Yang H. M., Cheresh D. A., Wargalla U., Sander D. J., Reisfeld R. A. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antigangl ioside GD2 antibody 14.18. Cancer Res. 1989; 49: 2857–2861
   PubMed Web of Science ®Google Scholar
• Cheresh D. A., Honsik C. J., Staffileno L. K., Jung G., Reisfeld R. A. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody‐mediated tumor cytolysis. Proc. Nat. Acad. Sci. (USA) 1985; 82: 5155–5159
   PubMed Web of Science ®Google Scholar
• Donoso L. A., Shields J. A., Augsburger J. J., Whitman J., Arbizo V. Antigenic and cellular heterogeneity of primary uveal malignant melanomas. Arch. Ophthalmol. 1986; 104: 106–110
   PubMedGoogle Scholar
• Greenlee J. E., Keeney P. M. Immunofluorescent labelling of K‐papovavirus antigens in glycol methacrylate embedded material: A method for studying infected cell populations by fluorescence microscopy and histological staining of adjacent sections. Stain Tech. 1982; 57: 197–205
   PubMed Web of Science ®Google Scholar
• Wordinger R. J., Miller G. W., Nicodemus D. S. Immunoperoxidase histochemistry in practice. Manual of Immunoperoxidase Techniques, R. J. Wordinger, G. W. Miller, D. S. Nicodemus. ASCP Press, Chicago 1987; 23–36
   Google Scholar
• Hsu S. ‐M., Raine L., Fanger H. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Niederkorn J. Y., Benson J. L., Mayhew E. Efferent blockade of delayed‐type hypersensitivity responses in the anterior chamber of the eye. Regional Immunol. 1991; 3: 349–354
   Google Scholar
• Fidler I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I‐5‐iodo‐2'‐deoxyuridine. J. Nat. Cancer Inst. 1970; 45: 773–782
   PubMed Web of Science ®Google Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 1: 571–573
   Google Scholar
• Ferrone P. J., Packer S., Albert D., Laster B., Fairchild R. The fate of circulating human choroidal melanoma cells in the nude mouse. Invest. Ophthalmol. Vis. Sci. 1989; 30: 59, (Suppl.)
   Google Scholar
• DeVore D. P., Houches D. P., Overjera A. A., Dill G. S., Hutson T. B. Collagenase inhibitors retarding invasion of a human tumor in nude mice. Exp. Cell Biol. 1980; 48: 367–373
   PubMedGoogle Scholar
• Sharkey F. E., Fogh J. Metastasis of human tumors in athymic nude mice. Int. J. Cancer 1979; 24: 733–738
   PubMed Web of Science ®Google Scholar
• Carrel S., Schreyer M., Gross N., Zografos L. Surface antigenic profile of uveal melanoma lesions analyzed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anticancer Res. 1990; 10: 81–90
   PubMed Web of Science ®Google Scholar
• van der Pol J. P., Jager M. J., de Wolff‐Roouendaal D., Ringens P. J., Vennegoor C., Ruiter D. J. Heterogeneous expression of melanoma‐associated antigens in uveal melanomas. Curr. Eye Res. 1987; 6: 757–765
   PubMed Web of Science ®Google Scholar
• Beckenkamp G., Schafer H., von Domarus D. Immunocytochemical parameters in ocular malignant melanoma. Eur. J. Cancer Clin. Oncol. 1988; 24: 41–45
   Google Scholar
• Natali P. G., Bigotti A., Nicotra M. R., Nardi R. M., Delovu A., Segatto O., Ferrone S. Analysis of the antigenic profile of uveal melanoma lesions with anticutaneous melanoma‐associated antigen and anti‐HLA monoclonal antibodies. Cancer Res. 1989; 49: 1269–1274
   PubMed Web of Science ®Google Scholar
• Soulieres D., Rousseau A., Deschenes J., Tremblay M., Tardif M., Pelletier G. Characterization of gangliosides in human uveal melanoma cells. Int. J. Cancer 1991; 49: 498–503
   PubMed Web of Science ®Google Scholar
• Heslop B. F., McNeilage L. J. Natural cytotoxicity: early killing of allogeneic lymphocytes in rats. Immunol. Rev. 1983; 73: 35–51
   PubMed Web of Science ®Google Scholar
• Thurin J., Thurin M., Kimoto Y., Herlyn M., Lubeck M. D., Elder D. E., Smereczynska M., Karlsson K‐A., Clark W. M., Jr, Steplewski Z., Koprowski H. Monoclonal antibody‐defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody‐mediated cytotoxicity. Cancer Res. 1987; 47: 1229–1233
   PubMed Web of Science ®Google Scholar
• Houghton A. N., Bajorin D. F., Lonberg M., Chapman P. Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside. Immunity to Cancer, M. S. Mitchell. Alan R. Liss, Inc., New York 1989; Vol. II: 383–390
   Google Scholar
• Handgretinger R., Baader P., Dopfer R., Klingebiel T., Reuland P., Treuner J., Reisfeld R. A., Niethammer D. A phase I study of neuroblastoma with the antiganglioside GD2 antibody 14.G2a. Cancer Immunol. Immunotherap. 1992; 35: 199–204
   PubMed Web of Science ®Google Scholar